Article Text

Download PDFPDF
Reminder of important clinical lesson
Malignant transformations in a patient with a mediastinal germ cell tumour: lack of efficacy of bone marrow transplantation after chemotherapy on tumour recurrence
  1. Yusra Kassim1,2,
  2. Dominique Penther3,
  3. Pascale Schneider4,
  4. Marie-Paul Callat4,
  5. Christian Bastard3,
  6. Jean-pierre Vannier4
  1. 1Pediatric Hemato-Oncology Department, CHU Charles Nicolle, Rouen, France
  2. 2Laboratoire MERCI, Faculte De Medecine, Rouen, France
  3. 3Molecular and Genetic Laboratory Department, Centre Henri Becquerel, Rouen, France
  4. 4CHU Charles Nicolle, Rouen, France
  1. Correspondence to Dr Yusra Kassim, yusra.sabri{at}univ-rouen.fr

Summary

The report describes the case of a young male with a malignant teratoma which was followed by an acute megakaryoblastic leukaemia sharing similar chromosomal abnormalities. In leukemic cells, the authors have obtained cytogenetic evidence by fluorescent in situ hybridisation technique suggesting that this leukaemia arose directly from the germ cell tumour (GCT). The patient received allogenic bone marrow transplantation, which unfortunately, did not prevent the patient to relapse with an undifferentiated sarcoma containing rhabdomyosarcoma components, as well as reappearance of a residual teratoma with metastasis. The treatment strategy for malignant transformation of a GCT seems to be unpredictable and should be dictated by the malignant tissue counterpart. Except for acute leukaemia, unresectable or metastatic settings will generally require multi-modal therapy including chemotherapy, in addition to loco regional approaches. Additionally, long or even a life time follow-up is necessary in patients with poor prognostic characteristics.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Patient consent Not obtained.